It has been demonstrated that in bladder cancer, especially in patients with poor prognosis, the overall abundance of m6A in tumor tissues is significantly increased and the expression levels of m6A-related regulators METTL3 and ALKBH5 are significantly abnormal (Han et al. 2019; Yu et al. 2021). This evidence concerns the gene METTL3 and urinary bladder cancer.